Clin2
NCT07462767Possibly a fitNot yet recruiting

Probiotic treatment for aging cells in HIV

HIV InfectionsAlcohol DrinkingAgingImmunosenescence

Part of Immune system & allergy, Infections clinical trials.

This study tests a special probiotic treatment to see if it can reduce aging-related cell damage in people with HIV who drink alcohol. It may help improve overall health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
160 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You are 40 years of age or older.
  • You have HIV.
  • You have had recent alcohol use (about 3 drinks or more in the past week).
  • You have not taken probiotics in the last 3 months.
  • You are not currently taking antibiotics or immune-suppressing medications.
  • You are not allergic to the study products, and you are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07415707Recruiting
Reducing alcohol and taking probiotics for brain health in older adults

This study tests whether cutting back on alcohol and taking probiotics can improve memory and thinking in older adults who are heavy drinkers. If you are interested in drinking less, you may be able to join.

Miami, Florida
NCT05288790Recruiting· Phase 2
Study how gut chemicals and alcohol affect heart risk in HIV

This Phase 2 study looks at how “microbiome metabolites” (chemicals from gut bacteria) and alcohol may affect heart and blood vessel risk in people living with HIV. If you qualify, you may be asked to follow a study plan to see how these factors change health markers related to cardiovascular disease.

Nashville, Tennessee
NCT05078957Recruiting
Study gut microbiome in older adults with well-controlled HIV

This trial studies how the bacteria in your gut (“microbiome”) relate to frailty (weakness/low physical resilience) in people with HIV who are stably doing well on treatment. It may help researchers understand why some people become frail and how the gut may play a role.

Marseille
NCT07341087Recruiting
Probiotic drink study for skin inflammation in menopause

This study tests whether a daily probiotic drink can improve inflammatory skin conditions like rosacea, acne, or eczema in women aged 40 to 60. You will take the drink for 8 weeks and provide blood, skin, stool samples, and a photo of your face.

London, London
NCT07202403Enrolling by invitation
Dietary supplements and aging therapy trial

This trial tests dietary supplements and other treatments aimed at slowing the effects of aging. It is looking for generally healthy adults who are not taking immune-altering medications or other conflicting therapies.

New York, New York
NCT06139224Recruiting
Gut Bacteria and Inflammation in HIV and Heavy Drinking

This study looks at how gut bacteria and inflammation interact in people with both HIV and heavy alcohol use. It aims to find new ways to improve health by understanding these connections.

Chicago, Illinois

Hear when a new HIV Infections trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.